Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis

Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis

Coronavirus disease 2019 (COVID-19) had caused huge health losses worldwide. Several drugs had been applied to treat patients with COVID-19, and repurposing colchicine had been proposed for its anti-inflammatory properties via several pathways. In this systematic review, we evaluated the effects of...

Full description

Bibliographic Details
Main Authors: Chi-Hone Lien, Ming-Dar Lee, Shun-Long Weng, Chao-Hsu Lin, Lawrence Yu-Min Liu, Yu-Lin Tai, Wei-Te Lei, Jui-Ming Liu, Ya-Ning Huang, Hsin Chi, Nan-Chang Chiu, Chien-Yu Lin
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Life
Subjects:
COVID-19
novel coronavirus
SARS-CoV-2
colchicine
immunomodulation
Online Access:https://www.mdpi.com/2075-1729/11/8/864

Internet

https://www.mdpi.com/2075-1729/11/8/864

Similar Items